Haplotypes of (-794(CATT)
Adult
Aged
Aged, 80 and over
Carcinoma, Basal Cell
/ genetics
Case-Control Studies
Female
Genetic Predisposition to Disease
Genotype
Haplotypes
Humans
Intramolecular Oxidoreductases
/ genetics
Macrophage Migration-Inhibitory Factors
/ genetics
Male
Mexico
Middle Aged
Polymorphism, Genetic
Skin Neoplasms
/ genetics
carcinoma
genetic
polymorphism
Journal
Journal of investigative medicine : the official publication of the American Federation for Clinical Research
ISSN: 1708-8267
Titre abrégé: J Investig Med
Pays: England
ID NLM: 9501229
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
accepted:
25
08
2020
pubmed:
14
10
2020
medline:
10
11
2021
entrez:
13
10
2020
Statut:
ppublish
Résumé
Basal cell carcinoma (BCC) is the most common dermatological neoplasms in Caucasian populations. In Mexico, a prevalence of 3.9 per 1000 habitants is estimated. Recently, the macrophage migration inhibitory factor (MIF) has been related to different types of cancer. Therefore, this study aimed to investigate the genetic association of haplotypes of [-794(CATT)5-8/-173G>C]MIF gene polymorphisms and its soluble levels in BCC. A total of 360 individuals were recruited for the study, that is, 180 of the total amounts were patients with BCC histologically confirmed and the remaining 180 individuals were identified as control subjects (CS). Both polymorphisms were genotyped by PCR and PCR-RFLP (restriction fragment length polymorphism), and MIF serum levels were measured by ELISA kit. A borderline difference was found between the 55 genotype and the susceptibility to BCC (5.6% vs 1.7% in BCC and CS, respectively, OR=3.7 and p=0.04). Furthermore, the haplotype 7G showed a significant association with BCC (p=0.02, OR=1.99). Concerning MIF soluble levels, patients with BCC showed a media of 2.1 ng/mL and CS showed 4.4 ng/mL, the comparison between groups was significant (p<0.01). Our findings suggest that the 55 genotype and the haplotype 7G are associated with the susceptibility to BCC; furthermore, a significant difference was found between MIF soluble levels in both study groups.
Identifiants
pubmed: 33046523
pii: jim-2020-001414
doi: 10.1136/jim-2020-001414
doi:
Substances chimiques
Macrophage Migration-Inhibitory Factors
0
Intramolecular Oxidoreductases
EC 5.3.-
MIF protein, human
EC 5.3.2.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
41-46Informations de copyright
© American Federation for Medical Research 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.